Niti Aayog wants most medical devices to be made in India

New Delhi: If Niti Ayog, govt think tank, is earnest in its intent, what it has expressed in its memorandum for consultation on medical devices should send Indian Medical Devices Industry in a bout of ecstasy. It has made all the right noises for the industry to be bullish about its bright future.

For Rjiv Nath, Coordinator of AIMED (Association of Indian Medical Device Industry), the memo and the proposed Medical Device Bill contains both song and lyric. He has gone gaga over consultation meeting.

Niti Aayog had called meeting all stakeholders to discuss its proposed Medical Device Bill. The memo sent to them is expression of its intent- The office memo says-   Appropriate, affordable and good quality medical devices are indispensable in healthcare services.  Access to safe, effective and effective and innovative medical devices is critical to ensure healthy lives and promote well being for all, at all ages. India is a booming market for consumption of medical technology. Ayushman Bharat PMJAY has further triggered an unprecedented demand for medical devices. It is also the government’s endeavour to make India medical products’ manufacturing and innovation hub for the world. Hitherto, a select group of medical devices in India have been regulated through the drugs and cosmetics Act 1940 .However there is a felt need for establishing a more enabling regulatory system in India to nurture and boost the medical devices sector.

The National Health Policy 2017 envisages strengthening the regulation of medical devices and establishing a regulatory body for medical devices to unleash innovation and the entrepreneurial spirit for manufacture of Medical devices in India.

Therefore, NITI has been engaged in developing a Medical Devices Bill. The purpose of the draft bill is to ensure that medical devices in India are safe and effective. Further, the bill should create an enabling ecosystem for manufacturing, research and innovation.

To take this process forward, Niti Aayog is inviting key stakeholders for a consultation.

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise